Literature DB >> 33662170

A qualitative exploration of fear of cancer recurrence in Turkish cancer survivors who were referred for colposcopy.

Fatma Ozlem Uner1, Oznur Korukcu2.   

Abstract

We aimed to qualitatively explore factors related to fear of cancer recurrence in women who had a risk of cervical cancer relapse/metastasis and to identify the psychological effect of gynaecological examination and colposcopy in cancer survivors. We conducted the present descriptive study with a qualitative design based on the thematic analysis approach on ten women who under suspicion of new cancer and were admitted to the Gynaecological Oncology Polyclinic of Akdeniz University for colposcopy between July and October 2017 via in-depth interviews. As a result of the interviews, we identified three main themes: colposcopy-related fear, emotions associated with fear of cancer recurrence, and fear of being diagnosed with cancer. Moreover it was determined that women experienced a fear of death, fear of family being affected, fear of stigmatisation by society, and fear of not coping with the treatment process. We found that women with cancer history and undergoing colposcopy because of abnormal cervical cytology in routine oncology controls experienced a significant fear of cancer recurrence. We found that gynaecological examination and colposcopy caused anxiety in patients. Healthcare professions should be aware and help women to cope with the fear of cancer recurrence in the colposcopy process and should determine the social care needs of these patients.
© 2021 John Wiley & Sons Ltd.

Entities:  

Keywords:  abnormal Pap test; colposcopy; fear of cancer recurrence; qualitative

Year:  2021        PMID: 33662170     DOI: 10.1111/hsc.13326

Source DB:  PubMed          Journal:  Health Soc Care Community        ISSN: 0966-0410


  1 in total

1.  The intrapersonal and interpersonal processes of fear of recurrence among cervical cancer survivors: a qualitative study.

Authors:  Yaira Hamama-Raz; Shiri Shinan-Altman; Inbar Levkovich
Journal:  Support Care Cancer       Date:  2021-11-24       Impact factor: 3.603

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.